Download the Article: 'Bigger than brand: Portfolio positioning for pharma'

With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.

Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Please enter your details so we can email you the content


In the precision medicine era, the line between products and services is blurred

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

Understanding COVID-19 and varying responses across the globe

At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.

Delivering impactful customer engagements in COVID-19

Blue Latitude Health, and our parent company Fishawack Health, have developed exclusive intellectual property, processes and tools to ensure you’re engaging customers in the right way. View our service one-pagers below to find out how we can help solve your challenges whether you’re in a medical, brand, portfolio or an above brand role.

SIGN UP TO OUR NEWSLETTER TO RECEIVE

  • Our latest articles on industry trends
  • Access to downloadable resources
  • Updates on pharma events and career opportunities
SIGN UP NOW